SpinaFX Medical today announced that it has appointed John Soloninka as chief operating officer.
Soloninka joins the minimally invasive image-guided therapy startup with more than 20 years of experience in health tech companies. Prior to joining the company, he was CEO and cofounder of a $28 million public/private venture debt fund where he oversaw a syndicated $86 million investment in 36 early-stage health tech companies like Synaptive Medical, Conavi, Spartan and Profound Medical.
“John brings an incredible combination of personal characteristics, skills, relevant expertise and strategic insights. His professional training, discipline, and entrepreneurial approach to business is invaluable to SpinaFX’s early-stage commercialization and growth. I am extremely pleased John as chosen to join us,” CEO Jeff Cambra said in a news release.
Soloninka has also cofounded an AI-based oncology management company that was acquired by Varian Medical Systems and cofounded a cloud-based medical imaging company that was later sold to Merge Technologies, which was purchased by IBM.
“I am delighted to join the SpinaFX team. Triojection has great potential to provide patients with an earlier, simpler back pain procedure, surgeons with a quicker, less-invasive treatment option, and payers with a lower cost per case,” Soloninka said. “Dr. Kieran Murphy, SpinaFX’s chief medical officer, has world-leading expertise in minimally invasive, image-guided technology innovation. Jeff Cambra, SpinaFX’s CEO, has been at the forefront of marketing transformative medical technologies for the global interventional spine market with Medtronic. My background complements these experts and together provides a great foundation to grow SpinaFX.”